Find a Trial
Trial Summary
| Protocol No. | PHO-MERCK-KEYNOTE-667 | ||
|---|---|---|---|
| Status | OPEN TO ACCRUAL | ||
| Principal Investigator | Belsky, Jenny | ||
| Scope | National | ||
| Phase | Phase II | ||
| Age Group | Children | ||
| Title | An Open-label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults with Newly Diagnosed Classical Hodgkin Lymphoma with Inadequate (Slow Early) Response to Frontline Chemotherapy (KEYNOTE 667) | ||
| Applicable Disease Sites | Hodgkin's Lymphoma | ||
| Participating Institutions | Indiana University (IU) | ||
| Treatment Type | Treatment | ||
| Contact | Heather Claussen, | Phone: Pager: Email: heclauss@iu.edu | |